Contemporary Management of HIV: Emerging Paradigms in ART

Download this expert-authored slideset to consider important clinical questions related to first-line ART, long-acting antiretroviral drugs, and 2-drug regimens for ART, with an emphasis on the role of new and emerging strategies.
Joseph J. Eron, Jr., MD
Program Director
Princy N. Kumar, MD, FIDSA, MACP
Program Director
David A. Wohl, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 562 KB
Released: March 17, 2021

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
ViiV Healthcare

Related Content

Slides from Dr Milena Murray and Clinical Care Options (CCO): Current pharmacokinetic and safety data support the use of tenofovir alafenamide during pregnancy

person default Milena Murray, PharmD, MSc, BCIDP, AAHIVP Released: September 24, 2021

Slides from Dr Jason Halperin and Clinical Care Options (CCO): Rapid ART in adolescents leads to virologic suppression and upholds equity

Jason Halperin, MD, MPH Released: September 24, 2021

Slides from Dr Jason Halperin and Clinical Care Options (CCO): Medication treatment for OUD improves HIV viral suppression rates

Jason Halperin, MD, MPH Released: September 24, 2021

From Dr. Eric Daar and CCO, slides covering new data from IAS 2021 expanding our understanding of the adverse event profiles of specific ART regimens

Eric S. Daar, MD Released: September 22, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue